With increasing information overload and packed work schedules, staying up-to-date on the newest oncologic advances is harder than ever. But take heart! The QuadShot is freshly brewed in your inbox four mornings each week so you can quickly down and digest the day's most pertinent cancer news.
The latest liquid gold rush is in the market for methylated cell-free DNA, which is touted in this preclinical study as a highly-sensitive, minimally-invasive and cost-effective means of early cancer detection. | Shen, Nature 2018